iRhythm Technologies (IRTC) Stock Overview
A digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
IRTC Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
iRhythm Technologies, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$169.12 |
| 52 Week High | US$172.59 |
| 52 Week Low | US$55.92 |
| Beta | 1.41 |
| 1 Month Change | 26.04% |
| 3 Month Change | 18.52% |
| 1 Year Change | 141.57% |
| 3 Year Change | 14.49% |
| 5 Year Change | -23.04% |
| Change since IPO | 549.21% |
Recent News & Updates
Recent updates
iRhythm Technologies, Inc. (NASDAQ:IRTC) Just Reported And Analysts Have Been Lifting Their Price Targets
Aug 04
Would iRhythm Technologies (NASDAQ:IRTC) Be Better Off With Less Debt?
Jul 21iRhythm: Promising Outlook - So Long As Past Mistakes Are Not Repeated
Jun 12
Ambulatory Monitoring And Digital Health Will Transform Global Markets
Accelerated global adoption of Zio and digital health integration is expanding iRhythm's market reach, operational efficiency, and recurring revenue streams.iRhythm Technologies, Inc.'s (NASDAQ:IRTC) Share Price Matching Investor Opinion
Apr 24Would iRhythm Technologies (NASDAQ:IRTC) Be Better Off With Less Debt?
Apr 03A Look At The Fair Value Of iRhythm Technologies, Inc. (NASDAQ:IRTC)
Feb 15Is It Too Late To Consider Buying iRhythm Technologies, Inc. (NASDAQ:IRTC)?
Jan 31What You Can Learn From iRhythm Technologies, Inc.'s (NASDAQ:IRTC) P/S
Jan 16iRhythm Technologies: Today's 510(K) Victory May Only Be A Temporary Reprieve
Oct 22Take Care Before Jumping Onto iRhythm Technologies, Inc. (NASDAQ:IRTC) Even Though It's 26% Cheaper
Oct 13Is iRhythm Technologies (NASDAQ:IRTC) A Risky Investment?
Sep 19Shareholder Returns
| IRTC | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 5.3% | 1.7% | 0.5% |
| 1Y | 141.6% | 5.8% | 15.7% |
Return vs Industry: IRTC exceeded the US Medical Equipment industry which returned 5.9% over the past year.
Return vs Market: IRTC exceeded the US Market which returned 15.7% over the past year.
Price Volatility
| IRTC volatility | |
|---|---|
| IRTC Average Weekly Movement | 6.6% |
| Medical Equipment Industry Average Movement | 8.2% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in US Market | 17.5% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: IRTC has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: IRTC's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 2,000 | Quentin Blackford | www.irhythmtech.com |
iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. It also provides Zio Monitor System, a prescription-only remote electrocardiogram (ECG) monitoring system consisting a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days; Zio XT System, a prescription-only remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and Zio ECG Utilization Software System, which supports the capture and analysis of ECG data.
iRhythm Technologies, Inc. Fundamentals Summary
| IRTC fundamental statistics | |
|---|---|
| Market cap | US$5.43b |
| Earnings (TTM) | -US$92.43m |
| Revenue (TTM) | US$657.23m |
Is IRTC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| IRTC income statement (TTM) | |
|---|---|
| Revenue | US$657.23m |
| Cost of Revenue | US$198.61m |
| Gross Profit | US$458.62m |
| Other Expenses | US$551.05m |
| Earnings | -US$92.43m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -2.88 |
| Gross Margin | 69.78% |
| Net Profit Margin | -14.06% |
| Debt/Equity Ratio | 625.1% |
How did IRTC perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/08/24 08:25 |
| End of Day Share Price | 2025/08/22 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
iRhythm Technologies, Inc. is covered by 26 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| David Rescott | Baird |
| Michael Polark | Baird |
| Joanne Wuensch | BMO Capital Markets Equity Research |